NYSE:SPHR
NYSE:SPHREntertainment

Sphere Entertainment Tests Smaller Sphere Model With Maryland National Harbor Plan

Sphere Entertainment (NYSE:SPHR) announced plans for a new venue at National Harbor in Maryland, its second U.S. location. The project will use a smaller scale design compared with the company’s existing U.S. venue. The development is expected to bring Sphere’s immersive entertainment concept to the Washington, D.C. metropolitan area. Company communications highlight anticipated economic, cultural, and community impacts, including job creation and public private investment. Sphere...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Is First Merchants (FRME) Pricing Look Attractive After Recent Regional Bank Sector Focus

If you are wondering whether First Merchants at around US$39.76 is a bargain or already priced for perfection, this breakdown is aimed at you. The stock has returned 4.4% over the last week and 6.1% over the last month, while the 1 year return sits at a 7.2% decline and the 5 year return is 16.3%. Recent market attention on regional banks and their balance sheet strength has kept names like First Merchants in focus, particularly among investors comparing financial health and profitability...
NYSE:CIEN
NYSE:CIENCommunications

Ciena Wins Key Global Network Deals As Valuation Stretches Further

Ciena's technology has been selected to power new high speed, low latency regional networks in Asia Pacific and Europe. Telekom Srbija is partnering with Ciena to advance digital connectivity across the Balkans. Trans Pacific Networks is using Ciena for subsea connectivity across the Asia Pacific region. Ciena (NYSE:CIEN) is drawing attention as its gear is picked for critical regional and subsea builds in Europe and Asia Pacific, positioning the company closer to the core of global data...
NYSE:OKE
NYSE:OKEOil and Gas

Does ONEOK’s Higher Dividend and New Directors Reframe Its Capital Allocation Priorities (OKE)?

In January 2026, ONEOK’s board increased its quarterly dividend to US$1.07 per share and added two independent directors, Mark A. McCollum and Precious Williams Owodunni, assigning them to key audit, governance, and executive compensation roles. These moves, alongside an insider share purchase by McCollum, highlight how ONEOK is reinforcing both its capital return approach and boardroom expertise in energy, finance, and governance. We’ll now examine how the dividend increase and refreshed...
NYSE:RTX
NYSE:RTXAerospace & Defense

A Look At RTX (RTX) Valuation After Strong Earnings Beat And New Defense Contract Wins

RTX (RTX) stock action has been driven by a busy earnings week, with the company posting stronger than expected Q4 and full year 2025 results, updating 2026 guidance, and landing fresh defense contracts. See our latest analysis for RTX. The strong Q4 and full year report, along with fresh defense wins on programs like Tomahawk, Patriot and the MS-110 system, have coincided with firm share price momentum. A 30 day share price return of 9.56% and a 1 year total shareholder return of 58.73%...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Exit From Offshore Wind Recasts Focus On Regulated Earnings

Eversource Energy (NYSE:ES) is exiting its offshore wind partnership with Orsted. The company plans to refocus on its core regulated utility operations following this exit. This change affects how Eversource allocates capital between renewables projects and regulated businesses. Eversource Energy runs regulated electric, gas, and water utilities, which typically follow defined rate frameworks set by regulators. Stepping away from the offshore wind joint venture signals a preference for...
NYSE:GM
NYSE:GMAuto

General Motors (GM) Is Up 5.4% After Bold 2026 Profit Guidance And Bigger Cash Returns

General Motors has reported full-year 2025 results showing revenue of US$185,019 million, net income of US$2,697 million, and diluted EPS of US$3.27, while also completing US$11,673.69 million of share repurchases and lifting its quarterly dividend to US$0.18 per share. Alongside these moves, GM issued 2026 guidance calling for net income attributable to stockholders of US$10.3 billion to US$11.7 billion and diluted EPS of US$11 to US$13, underlining management’s confidence even as it...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Is Fox (FOXA) Still Attractive After A 43.5% One Year Share Price Jump

If you are wondering whether Fox shares still offer value after recent gains, this article will walk through what the current price could be implying about the company. Fox closed at US$72.78, with returns of 43.5% over 1 year and 147.2% over 5 years. This is the case even though the stock is roughly flat over the last month and year to date. Recent price moves sit against a backdrop of ongoing interest in US media groups and how they position themselves across traditional TV and digital...
NYSE:F
NYSE:FAuto

Ford Expands Into Battery Storage As Investors Weigh Valuation And Growth Potential

Ford Motor (NYSE:F) has launched a new battery energy storage systems business, expanding its activities beyond electric vehicle manufacturing. Lisa Drake has been appointed president of the new unit, which will focus on battery energy storage solutions. The initiative includes repurposing existing facilities and a significant capital commitment to build out the new business. Ford Motor (NYSE:F), recently trading around $13.88, enters this move with a track record of substantial multi year...
NYSE:GIS
NYSE:GISFood

General Mills Refocuses Portfolio With Muir Glen Sale And Board Changes

General Mills has agreed to sell its Muir Glen organic tomato brand to Violet Foods, exiting a smaller organic canned tomato niche. The company also expanded its board with the appointment of Joan L. Bottarini as an independent director. General Mills amended its bylaws to update and strengthen its corporate governance framework. For investors watching NYSE:GIS, these moves come as the shares trade around $46.26, with a 7 day return of 3.8% and a 1 year return showing a 19.2% decline. Over...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq (NDAQ) Pricing Look Justified After Strong Multi Year Share Gains?

If you are asking whether Nasdaq stock looks reasonably priced or stretched right now, you are in the right place for a clear, valuation focused look at the numbers. The share price closed at US$96.89 recently, with returns of 19.1% over 1 year, 67.0% over 3 years and 118.2% over 5 years. Shorter term moves of a 1.2% decline over 7 days and a 0.2% decline over 30 days show a more muted picture. Recent coverage has focused on Nasdaq's role in capital markets infrastructure and ongoing...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial’s R4 Robot Extends Automation Push Into Specialty Crop Services

CNH Industrial (NYSE:CNH) has introduced its R4 autonomous robot, aimed at addressing labor shortages in specialty crop farming. The launch focuses on automated solutions for tasks in high value crops where finding and retaining workers can be difficult. This move builds on CNH Industrial's broader push into automation and robotics within agriculture equipment. For you as an investor, the R4 robot sits at the intersection of machinery, software, and farm operations, an area that has been...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Is Tilray Brands' (TLRY) Italian Medical Push Quietly Redefining Its Global Cannabis Strategy?

Earlier in January 2026, Tilray Medical, a division of Tilray Brands, expanded its European medical cannabis operations by launching Tilray Medical Italia, rebranding the former FL Group and broadening an Italian Ministry of Health–authorized product portfolio in partnership with Molteni Farmaceutici. This move not only deepens Tilray’s presence in one of Europe’s most tightly regulated medical cannabis markets, it also advances its goal of building a unified global medical cannabis platform...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

How Investors May Respond To Wave Life Sciences (WVE) Expanding PRISM RNA Platform Via Big-Pharma Partnerships

In recent months, Wave Life Sciences has drawn increased attention for its PRISM RNA medicines platform and its work with partners including GlaxoSmithKline, Takeda Pharmaceutical, and Asuragen to advance novel therapies. An interesting aspect of this story is how these collaborations may help Wave Life Sciences expand its research reach while sharing development and commercialization expertise with larger pharmaceutical companies. Next, we will examine how the PRISM RNA medicines platform...
NYSE:MOH
NYSE:MOHHealthcare

A Look At Molina Healthcare (MOH) Valuation After Medicare Advantage Payment Shock And Guidance Pressure

The Molina Healthcare (MOH) share move was driven by a policy shock after the Centers for Medicare & Medicaid Services proposed just a 0.09% net payment increase for 2027 Medicare Advantage plans. See our latest analysis for Molina Healthcare. At a share price of US$179.59, Molina’s recent 1 day share price return of a 2.89% decline and 7 day share price return of an 11.05% decline sit against a 90 day share price return of 17.33%. The 1 year total shareholder return of a 42.14% decline...
NYSE:EME
NYSE:EMEConstruction

How Investors May Respond To EMCOR Group (EME) Upgraded 2025 Outlook And Acquisition-Fueled Expansion

EMCOR Group has recently attracted positive attention after highlighting strong financial strength, profitability, and growth metrics, supported by rising demand across key electrical and mechanical construction end markets and several 2025 acquisitions, including Miller Electric. The company’s raised 2025 revenue, operating margin, and EPS outlook, alongside high-quality analyst endorsement, underscores management’s confidence and its perceived competitive position within facilities...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Immunocore Reshapes R&D Leadership As Shares Trade Below Analyst Targets

Immunocore Holdings (NasdaqGS:IMCR) announced an overhaul of its R&D leadership following the planned departure of EVP of Research & Development, Dr. David Berman. Instead of appointing a direct successor, the company is expanding the responsibilities of internal leaders Dr. Mohammed Dar and Mark Moyer. The leadership changes are expected to reshape how Immunocore manages clinical development and regulatory activities. Immunocore Holdings enters this leadership transition with its shares...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix Analyst Day Highlights Infection Prevention Plans For REZZAYO And DefenCath

CorMedix (NasdaqGM:CRMD) is hosting an analyst day focused on its late stage clinical programs. The event will feature updates on REZZAYO for fungal infection prophylaxis and DefenCath for catheter related bloodstream infection prevention. Management is expected to outline current program status and broader business direction for these key assets. For investors watching CorMedix, the focus is on how these late stage assets fit into the broader infection prevention space. REZZAYO and...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Recent Share Price Volatility And Rezdiffra Growth Expectations

Madrigal Pharmaceuticals (MDGL) has recently drawn attention after a mixed pattern in its share performance, with a negative month return but a positive move over the past 3 months and a strong one year total return. See our latest analysis for Madrigal Pharmaceuticals. Recent trading has been choppy, with a 30 day share price return of a 16% decline and a year to date share price return of an 18% decline, yet the 1 year total shareholder return of 46% suggests longer term momentum has still...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is Travere Therapeutics (TVTX) Offering Value After Recent Share Price Swings?

If you are wondering whether Travere Therapeutics at around US$31.09 is offering fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock has had a mixed run, with a 5.6% gain over the last 7 days but an 18.6% decline over 30 days, while still sitting on a 52.0% return over 1 year and 43.1% over 3 years, compared with a 2.1% decline over 5 years. Recent coverage of Travere Therapeutics has focused on its position in the...
NYSE:DUK
NYSE:DUKElectric Utilities

Duke Energy Winter Storm Response And Grid Resilience Story For Investors

Duke Energy prepared for severe winter weather in the Carolinas and Florida with grid hardening work and customer safety outreach. The company activated response plans as storms moved through, leading to widespread outages across parts of its service territory. Crews were deployed for large scale restoration efforts, supported by advanced self healing grid technologies aimed at shortening outages. Duke Energy, trading as NYSE:DUK, sits at the center of a major power reliability story as...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) Valuation Check As AI And HPC Financing And Contracts Gain Momentum

TeraWulf (WULF) is drawing fresh investor attention after securing large financing for high performance computing and AI facilities, backed by long term HPC contracts and support from partners such as Google and Fluidstack. See our latest analysis for TeraWulf. The latest funding news comes after a sharp pullback, with a 1 day share price return of an 8.05% decline and a 7 day share price return of a 5.31% decline. However, the 30 day share price return of 16.36% and the very large 3 year...
NYSE:GD
NYSE:GDAerospace & Defense

Is It Too Late To Consider General Dynamics (GD) After Its Strong Multi Year Run?

If you are wondering whether General Dynamics shares still offer value after a strong run, this article walks through what the current price might be implying about the business. The stock last closed at US$351.09, with a 1 year return of 39.3% and a 5 year return of 146.4%, while the past week shows a 3.4% decline and the past month a 4.3% gain. These figures can change how investors think about both opportunity and risk. Recent news coverage has focused on General Dynamics as a major US...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

F5 Lawsuits Test BIG IP Security Story And Growth Resilience

Multiple securities fraud class action lawsuits have been filed against F5, Inc. over an alleged failure to disclose a significant cybersecurity breach in its BIG-IP product. Regulatory investigations are reportedly examining whether F5 misrepresented the scope and impact of state-sponsored hacking and source code exfiltration. The actions focus on the potential gap between F5's prior public statements and the later disclosure of the BIG-IP security incident. F5, Inc. (NasdaqGS:FFIV)...